|
Diabetes, Vol 46, Issue 3 327-334, Copyright © 1997 by American Diabetes Association
The mystery of diabetes and atherosclerosis: time for a new plot
CF Semenkovich and JW Heinecke
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. semenkov@visar.wustl.edu
Most patients with diabetes die from macrovascular complications. Little is
known about the pathogenesis of diabetic vascular disease, but recent
advances in molecular genetics and oxidation chemistry provide clues to the
mystery of diabetes and atherosclerosis. Genetic variants of well-known
proteins such as lipoprotein lipase and apolipoprotein E are common. These
proteins are suitable candidates for mediating diabetic vascular risk
because their variants can produce hypertriglyceridemia, a risk factor for
atherosclerosis in diabetes. However, mutations could have different
effects on lipoprotein flux across arteries depending on whether expression
is dominant in the vascular space or the vascular wall. Lipoproteins
retained in the arterial wall are subject to oxidative modification, which
could be dependent on glycoxidation, the enzyme myeloperoxidase, or
reactive nitrogen species derived from nitric oxide. Accelerated vascular
disease in diabetes is likely the result of complex interactions between
metabolic derangements such as hyperglycemia, mutations in genes
controlling lipid metabolism, and antioxidant defense mechanisms.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Pennathur, Y. Ido, J. I. Heller, J. Byun, R. Danda, P. Pergola, J. R. Williamson, and J. W. Heinecke
Reactive Carbonyls and Polyunsaturated Fatty Acids Produce a Hydroxyl Radical-like Species: A POTENTIAL PATHWAY FOR OXIDATIVE DAMAGE OF RETINAL PROTEINS IN DIABETES
J. Biol. Chem.,
June 17, 2005;
280(24):
22706 - 22714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Quilliot, E. Walters, J.-P. Bonte, J.-C. Fruchart, P. Duriez, and O. Ziegler
Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis
Am. J. Clinical Nutrition,
May 1, 2005;
81(5):
1117 - 1125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ihara, S. Manabe, M. Kanda, H. Kawano, T. Nakayama, I. Sekine, T. Kondo, and Y. Ito
Increased expression of protein C-mannosylation in the aortic vessels of diabetic Zucker rats
Glycobiology,
April 1, 2005;
15(4):
383 - 392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barrett, G. King, M. Lopes-Virella, J. Reusch, N. Ruderman, G. Steiner, et al.
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
Circulation,
May 7, 2002;
105
(18):
e138 - e143.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Winegar, P. J. Brown, W. O. Wilkison, M. C. Lewis, R. J. Ott, W. Q. Tong, H. R. Brown, J. M. Lehmann, S. A. Kliewer, K. D. Plunket, et al.
Effects of fenofibrate on lipid parameters in obese rhesus monkeys
J. Lipid Res.,
October 1, 2001;
42(10):
1543 - 1551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, W. Hamouda, E. Assian, and S. Ahmad
Insulin Inhibits Intranuclear Nuclear Factor {{kappa}}B and Stimulates I{{kappa}}B in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect?
J. Clin. Endocrinol. Metab.,
July 1, 2001;
86(7):
3257 - 3265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Gerrity, R. Natarajan, J. L. Nadler, and T. Kimsey
Diabetes-Induced Accelerated Atherosclerosis in Swine
Diabetes,
July 1, 2001;
50(7):
1654 - 1665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Suzuki, M. Poot, R. G. Gerrity, and K. E. Bornfeldt
Diabetes Accelerates Smooth Muscle Accumulation in Lesions of Atherosclerosis: Lack of Direct Growth-Promoting Effects of High Glucose Levels
Diabetes,
April 1, 2001;
50(4):
851 - 860.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. S. Browner, L.-Y. Lui, and S. R. Cummings
Associations of Serum Osteoprotegerin Levels with Diabetes, Stroke, Bone Density, Fractures, and Mortality in Elderly Women
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
631 - 637.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Reue, P. Xu, X.-P. Wang, and B. G. Slavin
Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene
J. Lipid Res.,
July 1, 2000;
41(7):
1067 - 1076.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. L. Dixon, J. D. Stoops, J. L. Parker, M. H. Laughlin, G. A. Weisman, and M. Sturek
Dyslipidemia and Vascular Dysfunction in Diabetic Pigs Fed an Atherogenic Diet
Arterioscler. Thromb. Vasc. Biol.,
December 1, 1999;
19(12):
2981 - 2992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Hung, C.-H. Wang, and W.-J. Cherng
Can Dobutamine Stress Echocardiography Predict Cardiac Events in Nonrevascularized Diabetic Patients Following Acute Myocardial Infarction?
Chest,
November 1, 1999;
116(5):
1224 - 1232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Marshall, K. Tordjman, H. H. Host, N. J. Ensor, G. Kwon, C. A. Marshall, T. Coleman, M. L. McDaniel, and C. F. Semenkovich
Relative Hypoglycemia and Hyperinsulinemia in Mice with Heterozygous Lipoprotein Lipase (LPL) Deficiency. ISLET LPL REGULATES INSULIN SECRETION
J. Biol. Chem.,
September 24, 1999;
274(39):
27426 - 27432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kawano, T. Motoyama, O. Hirashima, N. Hirai, Y. Miyao, T. Sakamoto, K. Kugiyama, H. Ogawa, and H. Yasue
Hyperglycemia rapidly suppresses flow-mediated endothelium- dependent vasodilation of brachial artery
J. Am. Coll. Cardiol.,
July 1, 1999;
34(1):
146 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Schmidt, S. D. Yan, J.-L. Wautier, and D. Stern
Activation of Receptor for Advanced Glycation End Products : A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis
Circ. Res.,
March 19, 1999;
84(5):
489 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bittolo-Bon and G. Cazzolato
Analytical capillary isotachophoresis of total plasma lipoproteins: a new tool to identify atherogenic low density lipoproteins
J. Lipid Res.,
January 1, 1999;
40(1):
170 - 177.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. A. Towler, M. Bidder, T. Latifi, T. Coleman, and C. F. Semenkovich
Diet-induced Diabetes Activates an Osteogenic Gene Regulatory Program in the Aortas of Low Density Lipoprotein Receptor-deficient Mice
J. Biol. Chem.,
November 13, 1998;
273(46):
30427 - 30434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, M. S. Chua, and C. F. Semenkovich
Properties and purification of a glucose-inducible human fatty acid synthase mRNA-binding protein
Am J Physiol Endocrinol Metab,
April 1, 1998;
274(4):
E577 - E585.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|